Hemodynamic causes of deterioration in acute ischemic stroke

Perspectives in Medicine

Volumn 1-12, Issue 1-12, 2012, Pages 177-184

  Tsivgoulis, Georgios ^a   Apostolidou, Nicole ^a   Giannopoulos, Sotirios ^b   Sharma, Vijay K ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Acute ischemic stroke; Early neurological deterioration; Hemodynamic; Reocclusion; Transcranial Doppler

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN;

ARTERY REOCCLUSION; ARTERY STEAL SYNDROME; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; ECHOENCEPHALOGRAPHY; HEART ARRHYTHMIA; HEMODYNAMICS; HUMAN; INTRACARDIAC THROMBOSIS; METABOLIC DISORDER; NEUROLOGIC DISEASE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; REPERFUSION; REVASCULARIZATION; REVIEW; THROMBECTOMY; TREATMENT PLANNING;

EID: 84867576132     PISSN: 2211968X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.permed.2012.02.015     Document Type: Article

References (44)

1. Siegler JE, Martin-Schild S. Early neurological deterioration (END) after stroke: the END depends on the definition. Int J Stroke 2011;6:211-2.
2. Toni D, Fiorelli M, Zanette EM, Sacchetti ML, Salerno A, Argentino C, et al. Early spontaneous improvement and deterioration of ischemic stroke patients: A serial study with transcranial Doppler ultrasonography. Stroke 1998;29:1144-8.
3. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J, et al. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999;30:2631-6.
4. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32:661-8.
5. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM 2006;99:625-33.
6. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC, et al. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005;62:393-7.
7. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK, et al. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 2008;39:2318-24.
8. Prosser J, MacGregor L, Lees KR, Diener HC, Hacke W, Davis S. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 2007;38:2295-302.
9. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol 2010;9:105-18.
10. Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Manios E, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004;255:257-65.
11. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
12. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebocontrolled, double-blind trial. Lancet 2011;377:741-70.
13. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59:862-7.
14. Rubiera M, Alvarez-Sabín J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005;36:1452-6.
15. Burgin WS, Alexandrov AV. Deterioration following improvement with tPA therapy: carotid thrombosis and re-occlusion. Neurology 2001;56:568-70.
16. Baracchini C, Manara R, Ermani M, Meneghetti G. The quest for early predictors of stroke evolution: can TCD be a guiding light Stroke 2000;31:2942-7.
17. Qureshi AI, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani JF, et al. Reocclusion of recanalized arteries during intra-Arterial thrombolysis for acute ischemic stroke. Am J Neuroradiol 2004;25:322-8.
18. Rubiera M, Cava L, Tsivgoulis G, Patterson DE, Zhao L, Zhang Y, et al. Diagnostic criteria and yield of real-time transcranial Doppler monitoring of intra-Arterial reperfusion procedures. Stroke 2010;41:695-9.
19. Tsivgoulis G, Saqqur M, Demchuk AM, Rubiera M, Sharma VK, MolinaCA, et al. Predictors of early arterial reocclusion in patients with acute proximal arterial occlusions treated with intravenous thrombolysis. Stroke 2009;40:e157.
20. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005;36:2121-5.
21. Zhao L, Rubiera M, Harrigan MR, Alexandrov AV. Arterial reocclusion and persistent distal occlusion after thrombus aspiration. J Neuroimaging 2010;10:1552-6569.
22. Sugg RM, Pary JK, Uchino K, Baraniuk S, Shaltoni HM, Gonzales NR, et al. Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol 2006;63:1057-62.
23. Pranevicius M, Pranevicius O. Cerebral venous steal: blood flow diversion with increased tissue pressure. Neurosurgery 2002;51:1267-74.
24. Mosmans PC, Jonkman EJ. The significance of the collateral vascular system of the brain in shunt and steal syndromes. Clin Neurol Neurosurg 1980;82:145-56.
25. Schwartz A, Hennerici M. Noninvasive transcranial Doppler ultrasound in intracranial angiomas. Neurology 1986;36:626-635.
26. Tan TY, Schminke U, Chen TY. Hemodynamic effects of subclavian steal phenomenon on contralateral vertebral artery. J Clin Ultrasound 2006;34:77-81.
27. Alexandrov AV, Sharma VK, Lao AY, Tsivgoulis G, Malkoff MD, Alexandrov AW. Reversed Robin Hood syndrome in acute ischemic stroke patients. Stroke 2007;38:3045-8.
28. Tsivgoulis G, Sharma VK, Ardelt AA, Brenner D, Taylor M, Robinson A, et al. Reversed Robin Hood Syndrome: correlation of neurological deterioration with intracerebral steal magnitude. Stroke 2008;39:725.
29. Sharma VK, Tsivgoulis G, Ahmad A, Paliwal PR, Teoh HL, Wong LY, et al. Validation of 'Reversed Robin Hood Syndrome' by acetazolamide-challenged HMPA-SPECT in patients with severe steno-occlusive disease of intracranial carotid or middle cerebral artery. Stroke 2011;42:e227.
30. Sharma VK, Teoh HL, Paliwal PR, Chong VF, Chan BPL, Sinha AK. Reversed Robin Hood Syndrome in a patient with luxury perfusion after acute ischemic stroke. Circulation 2011;123: e243-4.
31. Alexandrov AV, Nguyen HT, Rubiera M, Alexandrov AW, Zhao L, Heliopoulos I, et al. Prevalence and risk factors associated with reversed Robin Hood syndrome in acute ischemic stroke. Stroke 2009;40:2738-42.
32. Palazzo P, Balucani C, Barlinn K, Tsivgoulis G, Zhang Y, Zhao L, et al. Association of reversed Robin Hood syndrome with risk of stroke recurrence. Neurology 2010;75:2003-8.
33. Tsivgoulis G, Zhang Y, Alexandrov AW, Harrigan MR, Sisson A, Zhao L, et al. Safety and tolerability of early noninvasive ventilatory correction using bilevel positive airway pressure in acute ischemic stroke. Stroke 2011;42:1030-4.
34. Barlinn K, Alexandrov AV. Sleep-disordered breathing and arterial blood flow steal represent linked therapeutic targets in cerebral ischaemia. Int J Stroke 2011;6:40-1.
35. King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-Analysis. Stroke 2009;40:3711-7.
36. Markus HS, King A, Shipley M, Topakian R, Cullinane M, Reihill S, et al. Asymptomatic embolisation predicts stroke in asymptomatic carotid stenosis: the Asymptomatic Carotid Emboli Study (ACES). Lancet Neurol 2010;9:663-71.
37. Markus HS, MacKinnon A. Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke 2005;36:971-5.
38. Hao Q, Leung WH, Leung C, Mok CT, Leung H, Soo Y, et al. The significance of microembolic signals and new cerebral infarcts on the progression of neurological deficit in acute stroke patients with large artery stenosis. Cerebrovasc Dis 2010;29:424-30.
39. Tsivgoulis G, Alexandrov AV, Sloan MA. Advances in transcranial Doppler ultrasonography. Curr Neurol Neurosci Rep 2009;9:46-54.
40. Iguchi Y, Kimura K, Kobayashi K, Ueno Y, Shibazaki K, Inoue T. Microembolic signals at 48 h after stroke onset contribute to new ischaemia within a week. Neurol Neurosurg Psychiatry 2008;79:253-325.
41. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation 2005;111:2233-40.
42. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al., CLAIR study investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010;9:489-97.
43. Kaste M. Time matters for reducing risk of stroke. Lancet Neurol 2010;9:451-3.
44. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke 2011;42:e420-63.